Connection

Anthony Fauci to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Anthony Fauci has written about Antibodies, Monoclonal.
Anthony Fauci
Connection Strength
0.443
Antibodies, Monoclonal
  1. An open-label phase 1 clinical trial of the anti-a4ß7 monoclonal antibody vedolizumab in HIV-infected individuals. Sci Transl Med. 2019 09 11; 11(509).
    View in: PubMed
    Score: 0.203
  2. Monoclonal Antibodies for Emerging Infectious Diseases - Borrowing from History. N Engl J Med. 2018 Apr 19; 378(16):1469-1472.
    View in: PubMed
    Score: 0.183
  3. Signal peptide of HIV envelope protein impacts glycosylation and antigenicity of gp120. Proc Natl Acad Sci U S A. 2018 03 06; 115(10):2443-2448.
    View in: PubMed
    Score: 0.046
  4. Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to a4ß7. PLoS Pathog. 2018 08; 14(8):e1007278.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.